Detalles de la búsqueda
1.
A cost-utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom.
J Med Econ
; 17(4): 233-47, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24568188
2.
Cost and quality-adjusted life year differences in the treatment of active ulcerative colitis using once-daily 4 g or twice-daily 2g mesalazine dosing.
J Crohns Colitis
; 8(5): 357-62, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24094599
3.
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial.
J Crohns Colitis
; 3(1): 32-7, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21172245
4.
An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial.
J Crohns Colitis
; 3(3): 168-74, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21172266
Resultados
1 -
4
de 4
1
Próxima >
>>